Broadly neutralizing antibodies target the coronavirus fusion peptide
Read More
La Jolla Institute for Immunology Acquires LSA Platform
Read More
Carterra Joins the Tetra Partner Network to Advance Therapeutics Discovery
Read More
University of Manchester Adds Carterra’s LSA Instrument for High-Throughput Antibody Screening and Characterization
Read More
Carterra celebrates the 100th LSA shipped
Read More
Carterra awarded 10 Fastest Growing Life Sciences Companies to Watch in 2022
Read More
Genovac Acquires the Carterra LSA Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services
Read More
High resolution FcRn IC50 potency measurements using the Carterra LSA platform
Read More
Profiling antibody polyreactivity and polyspecificity using HT-SPR on the Carterra LSA
Read More
Expert View: Transforming biotherapeutic development post-pandemic
Read More
